Publication:
Orlistat is a fatty acid synthase (FASN) inhibitor caused the modulation of AMPK and lipogenesis signaling axis in PC3 prostate cancer cells but not in PNT1A prostate epithelial cells

dc.contributor.authorNebiler, E.
dc.contributor.authorAdacan, K.
dc.contributor.authorÇoker Gürkan, Ajda
dc.contributor.authorPalavan Ünsal, Zeynep Narçın
dc.contributor.authorARISAN, ELİF DAMLA
dc.contributor.authorYERLİKAYA, PINAR OBAKAN
dc.contributor.authorID113920tr_TR
dc.contributor.authorID125860tr_TR
dc.contributor.authorID156421tr_TR
dc.contributor.authorID6125tr_TR
dc.date.accessioned2018-07-20T12:04:20Z
dc.date.available2018-07-20T12:04:20Z
dc.date.issued2017-09
dc.identifier.issn1742-464X
dc.identifier.other1742-4658
dc.identifier.urihttps://hdl.handle.net/11413/2230
dc.identifier.wos409918904190
dc.identifier.wos409918904190en
dc.language.isoen_UStr_TR
dc.publisherWiley, 111 River St, Hoboken 07030-5774, NJ USAtr_TR
dc.relationFebs Journaltr_TR
dc.titleOrlistat is a fatty acid synthase (FASN) inhibitor caused the modulation of AMPK and lipogenesis signaling axis in PC3 prostate cancer cells but not in PNT1A prostate epithelial cellstr_TR
dc.typeArticle
dspace.entity.typePublication
local.indexed.atwos
relation.isAuthorOfPublication3d33e154-a50c-46b8-ad6e-25a26bf11cf0
relation.isAuthorOfPublication387670e2-5a88-4937-b3da-1dda9aedfbdd
relation.isAuthorOfPublication.latestForDiscovery3d33e154-a50c-46b8-ad6e-25a26bf11cf0

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: